Oral fixed drug eruption: Analyses of reported cases in the literature

This analytic study aimed to summarize the data regarding OFDEs manifestations and characteristics available up to date. We searched online databases for relevant articles and summarized their data regarding age, gender, Main drug classification and name, additional drugs, dosages, primary disorders...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of stomatology, oral and maxillofacial surgery oral and maxillofacial surgery, 2022-10, Vol.123 (5), p.e355-e363
Hauptverfasser: Mortazavi, Hamed, Nobar, Behrad Rahbani, Shafiei, Shervin, Moslemi, Hamidreza, Ahmadi, Nima, Hazrati, Parham
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e363
container_issue 5
container_start_page e355
container_title Journal of stomatology, oral and maxillofacial surgery
container_volume 123
creator Mortazavi, Hamed
Nobar, Behrad Rahbani
Shafiei, Shervin
Moslemi, Hamidreza
Ahmadi, Nima
Hazrati, Parham
description This analytic study aimed to summarize the data regarding OFDEs manifestations and characteristics available up to date. We searched online databases for relevant articles and summarized their data regarding age, gender, Main drug classification and name, additional drugs, dosages, primary disorders, OFDE presentation and location, extra-oral presentation and location, follow-up, and treatment. The mean age of OFDE-affected patients was 38.9. Most of the reported cases were between 30 and 60 years of age. The female/male ratio was 1.12/1. Three drug classifications, which were mainly associated with OFDEs, were analgesics (27.8%), antibiotics (22.2%), and antifungals (11.1%). The most common additional drugs were oral contraceptives and corticosteroids. The three most prevalent disorders or conditions were infectious disease (23.7%), pain (13.2%) and auto-immune disease (10.5%). Erythematous lesions without blister (38.9%), lichenoid drug eruptions (16.7%), blisters/vesicles (13.9%) and ulcers (13.9%) were the most common manifestations of OFDEs. The rarest manifestation of OFDE was pigmentation. Lips, tongue, buccal mucosa, palate and gingiva were the sites in which OFDEs occurred in the included studies. Similar to OFDEs, erythematous lesions without blisters and lichenoid drug eruptions were the most prevalent extra-oral manifestations. The most common time for OFDE manifestations was one to three days after taking the drug. Due to the similarities between the reported cases of OFDEs, clinicians should familiarize themselves with OFDE cases in order to screen suspected patients effectively.
doi_str_mv 10.1016/j.jormas.2022.04.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2653268816</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2468785522000969</els_id><sourcerecordid>2653268816</sourcerecordid><originalsourceid>FETCH-LOGICAL-c292t-58dca0a812eff8d1601936607994c732efb03923b4897469e31e2159a1969b453</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRrNT-A5EcvSTuVza7HoRSrAqFXvS8bDYT3ZAvdxOx_96UVvHkaYbheWeYB6ErghOCibitkqrzjQkJxZQmmCcYZyfognIh40ym6emffoYWIVQYYyKpEDw9RzOWcs4o4RdovfWmjkr3BUVU-PEtAj_2g-vau2jZmnoXIERdGXnoOz9MjDX7iWuj4R2i2g3gzTB6uERnpakDLI51jl7XDy-rp3izfXxeLTexpYoOcSoLa7CRhEJZyoIITBQTAmdKcZuxaZpjpijLuVQZFwoYAUpSZYgSKucpm6Obw97edx8jhEE3Llioa9NCNwZNRcqokJKICeUH1PouBA-l7r1rjN9pgvVeoq70QaLeS9SY60niFLs-XhjzBorf0I-yCbg_ADD9-enA62AdtBYK58EOuujc_xe-ATJKguk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2653268816</pqid></control><display><type>article</type><title>Oral fixed drug eruption: Analyses of reported cases in the literature</title><source>Alma/SFX Local Collection</source><creator>Mortazavi, Hamed ; Nobar, Behrad Rahbani ; Shafiei, Shervin ; Moslemi, Hamidreza ; Ahmadi, Nima ; Hazrati, Parham</creator><creatorcontrib>Mortazavi, Hamed ; Nobar, Behrad Rahbani ; Shafiei, Shervin ; Moslemi, Hamidreza ; Ahmadi, Nima ; Hazrati, Parham</creatorcontrib><description>This analytic study aimed to summarize the data regarding OFDEs manifestations and characteristics available up to date. We searched online databases for relevant articles and summarized their data regarding age, gender, Main drug classification and name, additional drugs, dosages, primary disorders, OFDE presentation and location, extra-oral presentation and location, follow-up, and treatment. The mean age of OFDE-affected patients was 38.9. Most of the reported cases were between 30 and 60 years of age. The female/male ratio was 1.12/1. Three drug classifications, which were mainly associated with OFDEs, were analgesics (27.8%), antibiotics (22.2%), and antifungals (11.1%). The most common additional drugs were oral contraceptives and corticosteroids. The three most prevalent disorders or conditions were infectious disease (23.7%), pain (13.2%) and auto-immune disease (10.5%). Erythematous lesions without blister (38.9%), lichenoid drug eruptions (16.7%), blisters/vesicles (13.9%) and ulcers (13.9%) were the most common manifestations of OFDEs. The rarest manifestation of OFDE was pigmentation. Lips, tongue, buccal mucosa, palate and gingiva were the sites in which OFDEs occurred in the included studies. Similar to OFDEs, erythematous lesions without blisters and lichenoid drug eruptions were the most prevalent extra-oral manifestations. The most common time for OFDE manifestations was one to three days after taking the drug. Due to the similarities between the reported cases of OFDEs, clinicians should familiarize themselves with OFDE cases in order to screen suspected patients effectively.</description><identifier>ISSN: 2468-7855</identifier><identifier>EISSN: 2468-7855</identifier><identifier>DOI: 10.1016/j.jormas.2022.04.007</identifier><identifier>PMID: 35443214</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Drugs ; Fixed drug eruption ; Pharmacotherapy</subject><ispartof>Journal of stomatology, oral and maxillofacial surgery, 2022-10, Vol.123 (5), p.e355-e363</ispartof><rights>2022 Elsevier Masson SAS</rights><rights>Copyright © 2022 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c292t-58dca0a812eff8d1601936607994c732efb03923b4897469e31e2159a1969b453</citedby><cites>FETCH-LOGICAL-c292t-58dca0a812eff8d1601936607994c732efb03923b4897469e31e2159a1969b453</cites><orcidid>0000-0002-0415-4678 ; 0000-0002-8362-3208</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35443214$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mortazavi, Hamed</creatorcontrib><creatorcontrib>Nobar, Behrad Rahbani</creatorcontrib><creatorcontrib>Shafiei, Shervin</creatorcontrib><creatorcontrib>Moslemi, Hamidreza</creatorcontrib><creatorcontrib>Ahmadi, Nima</creatorcontrib><creatorcontrib>Hazrati, Parham</creatorcontrib><title>Oral fixed drug eruption: Analyses of reported cases in the literature</title><title>Journal of stomatology, oral and maxillofacial surgery</title><addtitle>J Stomatol Oral Maxillofac Surg</addtitle><description>This analytic study aimed to summarize the data regarding OFDEs manifestations and characteristics available up to date. We searched online databases for relevant articles and summarized their data regarding age, gender, Main drug classification and name, additional drugs, dosages, primary disorders, OFDE presentation and location, extra-oral presentation and location, follow-up, and treatment. The mean age of OFDE-affected patients was 38.9. Most of the reported cases were between 30 and 60 years of age. The female/male ratio was 1.12/1. Three drug classifications, which were mainly associated with OFDEs, were analgesics (27.8%), antibiotics (22.2%), and antifungals (11.1%). The most common additional drugs were oral contraceptives and corticosteroids. The three most prevalent disorders or conditions were infectious disease (23.7%), pain (13.2%) and auto-immune disease (10.5%). Erythematous lesions without blister (38.9%), lichenoid drug eruptions (16.7%), blisters/vesicles (13.9%) and ulcers (13.9%) were the most common manifestations of OFDEs. The rarest manifestation of OFDE was pigmentation. Lips, tongue, buccal mucosa, palate and gingiva were the sites in which OFDEs occurred in the included studies. Similar to OFDEs, erythematous lesions without blisters and lichenoid drug eruptions were the most prevalent extra-oral manifestations. The most common time for OFDE manifestations was one to three days after taking the drug. Due to the similarities between the reported cases of OFDEs, clinicians should familiarize themselves with OFDE cases in order to screen suspected patients effectively.</description><subject>Drugs</subject><subject>Fixed drug eruption</subject><subject>Pharmacotherapy</subject><issn>2468-7855</issn><issn>2468-7855</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kE1Lw0AQhhdRrNT-A5EcvSTuVza7HoRSrAqFXvS8bDYT3ZAvdxOx_96UVvHkaYbheWeYB6ErghOCibitkqrzjQkJxZQmmCcYZyfognIh40ym6emffoYWIVQYYyKpEDw9RzOWcs4o4RdovfWmjkr3BUVU-PEtAj_2g-vau2jZmnoXIERdGXnoOz9MjDX7iWuj4R2i2g3gzTB6uERnpakDLI51jl7XDy-rp3izfXxeLTexpYoOcSoLa7CRhEJZyoIITBQTAmdKcZuxaZpjpijLuVQZFwoYAUpSZYgSKucpm6Obw97edx8jhEE3Llioa9NCNwZNRcqokJKICeUH1PouBA-l7r1rjN9pgvVeoq70QaLeS9SY60niFLs-XhjzBorf0I-yCbg_ADD9-enA62AdtBYK58EOuujc_xe-ATJKguk</recordid><startdate>20221001</startdate><enddate>20221001</enddate><creator>Mortazavi, Hamed</creator><creator>Nobar, Behrad Rahbani</creator><creator>Shafiei, Shervin</creator><creator>Moslemi, Hamidreza</creator><creator>Ahmadi, Nima</creator><creator>Hazrati, Parham</creator><general>Elsevier Masson SAS</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0415-4678</orcidid><orcidid>https://orcid.org/0000-0002-8362-3208</orcidid></search><sort><creationdate>20221001</creationdate><title>Oral fixed drug eruption: Analyses of reported cases in the literature</title><author>Mortazavi, Hamed ; Nobar, Behrad Rahbani ; Shafiei, Shervin ; Moslemi, Hamidreza ; Ahmadi, Nima ; Hazrati, Parham</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c292t-58dca0a812eff8d1601936607994c732efb03923b4897469e31e2159a1969b453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Drugs</topic><topic>Fixed drug eruption</topic><topic>Pharmacotherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mortazavi, Hamed</creatorcontrib><creatorcontrib>Nobar, Behrad Rahbani</creatorcontrib><creatorcontrib>Shafiei, Shervin</creatorcontrib><creatorcontrib>Moslemi, Hamidreza</creatorcontrib><creatorcontrib>Ahmadi, Nima</creatorcontrib><creatorcontrib>Hazrati, Parham</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of stomatology, oral and maxillofacial surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mortazavi, Hamed</au><au>Nobar, Behrad Rahbani</au><au>Shafiei, Shervin</au><au>Moslemi, Hamidreza</au><au>Ahmadi, Nima</au><au>Hazrati, Parham</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral fixed drug eruption: Analyses of reported cases in the literature</atitle><jtitle>Journal of stomatology, oral and maxillofacial surgery</jtitle><addtitle>J Stomatol Oral Maxillofac Surg</addtitle><date>2022-10-01</date><risdate>2022</risdate><volume>123</volume><issue>5</issue><spage>e355</spage><epage>e363</epage><pages>e355-e363</pages><issn>2468-7855</issn><eissn>2468-7855</eissn><abstract>This analytic study aimed to summarize the data regarding OFDEs manifestations and characteristics available up to date. We searched online databases for relevant articles and summarized their data regarding age, gender, Main drug classification and name, additional drugs, dosages, primary disorders, OFDE presentation and location, extra-oral presentation and location, follow-up, and treatment. The mean age of OFDE-affected patients was 38.9. Most of the reported cases were between 30 and 60 years of age. The female/male ratio was 1.12/1. Three drug classifications, which were mainly associated with OFDEs, were analgesics (27.8%), antibiotics (22.2%), and antifungals (11.1%). The most common additional drugs were oral contraceptives and corticosteroids. The three most prevalent disorders or conditions were infectious disease (23.7%), pain (13.2%) and auto-immune disease (10.5%). Erythematous lesions without blister (38.9%), lichenoid drug eruptions (16.7%), blisters/vesicles (13.9%) and ulcers (13.9%) were the most common manifestations of OFDEs. The rarest manifestation of OFDE was pigmentation. Lips, tongue, buccal mucosa, palate and gingiva were the sites in which OFDEs occurred in the included studies. Similar to OFDEs, erythematous lesions without blisters and lichenoid drug eruptions were the most prevalent extra-oral manifestations. The most common time for OFDE manifestations was one to three days after taking the drug. Due to the similarities between the reported cases of OFDEs, clinicians should familiarize themselves with OFDE cases in order to screen suspected patients effectively.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>35443214</pmid><doi>10.1016/j.jormas.2022.04.007</doi><orcidid>https://orcid.org/0000-0002-0415-4678</orcidid><orcidid>https://orcid.org/0000-0002-8362-3208</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2468-7855
ispartof Journal of stomatology, oral and maxillofacial surgery, 2022-10, Vol.123 (5), p.e355-e363
issn 2468-7855
2468-7855
language eng
recordid cdi_proquest_miscellaneous_2653268816
source Alma/SFX Local Collection
subjects Drugs
Fixed drug eruption
Pharmacotherapy
title Oral fixed drug eruption: Analyses of reported cases in the literature
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T08%3A56%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20fixed%20drug%20eruption:%20Analyses%20of%20reported%20cases%20in%20the%20literature&rft.jtitle=Journal%20of%20stomatology,%20oral%20and%20maxillofacial%20surgery&rft.au=Mortazavi,%20Hamed&rft.date=2022-10-01&rft.volume=123&rft.issue=5&rft.spage=e355&rft.epage=e363&rft.pages=e355-e363&rft.issn=2468-7855&rft.eissn=2468-7855&rft_id=info:doi/10.1016/j.jormas.2022.04.007&rft_dat=%3Cproquest_cross%3E2653268816%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2653268816&rft_id=info:pmid/35443214&rft_els_id=S2468785522000969&rfr_iscdi=true